相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances
John Martin Corkery et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
The clinical challenges of synthetic cathinones
Fabrizio Schifano et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports
Laura Orsolini et al.
CURRENT NEUROPHARMACOLOGY (2020)
Novel Opioids: Systematic Web Crawling Within the e-Psychonauts' Scenario
Davide Arillotta et al.
FRONTIERS IN NEUROSCIENCE (2020)
COVID-19: The Hidden Impact on Mental Health and Drug Addiction
Stefania Chiappini et al.
FRONTIERS IN PSYCHIATRY (2020)
Coming Off Prescribed Psychotropic Medications: Insights from Their Use as Recreational Drugs
Fabrizio Schifano
PSYCHOTHERAPY AND PSYCHOSOMATICS (2020)
Pregabalin: A range of misuse-related unanswered questions
Fabrizio Schifano et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
Characteristics of deaths associated with kratom use
John M. Corkery et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Combined NMDA Inhibitor Use in a Patient With Multisubstance-induced Psychotic Disorder
Matteo Caloro et al.
JOURNAL OF ADDICTION MEDICINE (2018)
Is There a Potential of Misuse for Venlafaxine and Bupropion?
Fabrizio Schifano et al.
FRONTIERS IN PHARMACOLOGY (2018)
Psychedelic Fauna for Psychonaut Hunters: A Mini-Review
Laura Orsolini et al.
FRONTIERS IN PSYCHIATRY (2018)
Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports
Fabrizio Schifano et al.
PLOS ONE (2018)
Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom Communities Associated with GHB and Precursors
John M. Corkery et al.
CURRENT DRUG METABOLISM (2018)
Addiction-related interactions of pregabalin with morphine in mice and humans: reinforcing and inhibiting effects
Elena Vashchinkina et al.
ADDICTION BIOLOGY (2018)
How addictive are gabapentin and pregabalin? A systematic review
U. Bonnet et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
From concept(ion) to life after death/the grave: The natural' history and life cycle(s) of novel psychoactive substances (NPS)
John Martin Corkery et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2017)
An insight into the deep web; why it matters for addiction psychiatry?
Laura Orsolini et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2017)
The Endless Trip among the nPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review
Laura Orsolini et al.
FRONTIERS IN PSYCHIATRY (2017)
Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism?
Laura Orsolini et al.
CURRENT NEUROPHARMACOLOGY (2017)
When Chems Meet Sex: A Rising Phenomenon Called ChemSex
Raffaele Giorgetti et al.
CURRENT NEUROPHARMACOLOGY (2017)
Herbal Highs: Review on Psychoactive Effects and Neuropharmacology
Silvia Graziano et al.
CURRENT NEUROPHARMACOLOGY (2017)
A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database
Stefania Chiappini et al.
CNS DRUGS (2016)
Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135
Maria Antonietta De Luca et al.
NEUROPHARMACOLOGY (2016)
Novel psychoactive substances: the pharmacology of stimulants and hallucinogens
Fabrizio Schifano et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
Venlafaxine as the baby ecstasy'? Literature overview and analysis of web-based misusers experiences
Giulia Francesconi et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2015)
Olanzapine as the ideal trip terminator? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms
Giuseppe Valeriani et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2015)
Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use
John M. Corkery et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Novel psychoactive substances of interest for psychiatry
Fabrizio Schifano et al.
WORLD PSYCHIATRY (2015)
Mind Navigators of Chemicals' Experimenters? A Web-Based Description of E-Psychonauts
Laura Orsolini et al.
CYBERPSYCHOLOGY BEHAVIOR AND SOCIAL NETWORKING (2015)
Legal highs: staying on top of the flood of novel psychoactive substances
David Baumeister et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2015)
Noids in a nutshell: everything you (don't) want to know about synthetic cannabimimetics
Duccio Papanti et al.
ADVANCES IN DUAL DIAGNOSIS (2014)
Spiceophrenia: a systematic overview of Spice-related psychopathological issues and a case report
Duccio Papanti et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2013)
Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey
Pierluigi Simonato et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2013)
Dissociation of rewarding, anti-aversive and anti-nociceptive effects of different classes of anti-nociceptives in the rat
Kris Rutten et al.
EUROPEAN JOURNAL OF PAIN (2011)
'Pharming': the abuse of prescription and over-the-counter drugs in teens
Deborah A. Levine
CURRENT OPINION IN PEDIATRICS (2007)
分享论文
